Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracelular lipid deposits

Journal of Physiology and Pharmacology

Volumn 58, Issue 1, 2007, Pages 73-82

  Chabowski, A ^a   Zmijewska, M ^a   Gorski J ^a   Bonen, A ^b   Kaminski K ^a   Winnicka, M M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

FABPpm; FAT CD36; FATP 1; Heart; IL 6; Lipids

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; FATTY ACID; FATTY ACID TRANSPORTER; INTERLEUKIN 6; CD36 ANTIGEN; SLC27A1 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FATTY ACID ANALYSIS; FEMALE; LIPID COMPOSITION; LIPID STORAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; C57BL MOUSE; GENETICS; HEART MUSCLE; LIPID METABOLISM; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTIGENS, CD36; CERAMIDES; DIGLYCERIDES; FATTY ACID TRANSPORT PROTEINS; FATTY ACIDS, NONESTERIFIED; FEMALE; INTERLEUKIN-6; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM;

EID: 34248203080     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83:847-850
2. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8:75-79
3. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40:1286-1292
4. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280:E745-751
5. Carey AL, Lamont B, Andrikopoulos S, Koukoulas I, Proietto J, Febbraio MA. Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation. Biochem Biophys Res Commun 2003; 302:837-840
6. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, Febbraio MA. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 2001; 533(Pt 2):585-591
7. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280:E745-751
8. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005; 1734:112-126
9. Ghosh S, An D, Pulinilkunnil T, Qi D, Lau HC, Abraham A, Innis SM, Rodrigues B. Role of dietary fatty acids and acute hyperglycemia in modulating cardiac cell death. Nutrition 2004; 20:916-923
10. Zhou YT. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad SCi USA 2000; 97: 1784-1789
11. Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 2000; 24 Suppl 4:S28-32
12. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 2002; 51: 2587-2595
13. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 1984; 55:135-154
14. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000; 279: E1039-E1044
15. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999; 277(6 Pt 1):E1130-1141
16. Luiken JJFP, Arumugam Y, Bell RC, et al. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab 2002; 283:E612-621
17. Luiken JJFP, Arumugam Y, Dyck DJ, et al. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 2001; 276:40567-40573
18. Bonen A, Glatz JF Luiken JJFP. Regulation of fatty acid transport and membrane transporters in health and disease. Mol Cell Biochem 2002; 239: 181-192.
19. Schaffer JE. Fatty acid transport: the roads taken. Am J Physiol Endocrinol Metab 2002: 282: E239-E246
20. Bonen A, Campbell SE, Benton CR, et al. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc 2004; 63:245-249
21. Luiken JJ, Turcotte LP, Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 1999; 40:1007-1016
22. Koonen DP, Glatz JF, Bonen A, Luiken JJ. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta 2005; 1736:163-180
23. Chabowski A, Coort SL, Calles-Escandon J, et al. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett 2005; 579:2428-2432
24. Matsuno K, Diaz-Ricard M, Montgomery RR, Aster T, Jamieson GA, Tandon NN. Inhibition of platelet adhesion to collagen by monoclonal anti CD36 antibodies. Br J Haematol 1996; 92: 960-967
25. Calles-Escandon J, Sweet L, Ljungqvist O, Hirshman MF. The membrane associated 40 kDa fatty acid binding protein is present in human skeletal muscle. Life Sci 1996; 58: 19-28
26. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509
27. Van der Vusse, GJ, Roemen, THM, Reneman RS. Assessment of fatty acids in dog left ventricular myocardium. Biochim Biophys Acta 1980; 617: 347-352
28. Chabowski A, Coort SL, Calles-Escandon J, et al. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am J Physiol Endocrinol Metab 2004; 287 (4): E781- E789
29. Lavrentyev EN, He D, Cook GA. Mistaken identity or yet another case of species difference? Am J Physiol Heart Circ Physiol 2005; 288: H448-H450
30. Bonen A, Miskovic D, Kiens B. Fatty acid transporters (FABPpm, FAT, FATP) in human muscle. Can J Appl Physiol 1999; 24: 515-523
31. Gimeno RE, Ortegon AM, Patel S, et al. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 2003; 278:16039-16044
32. Coort SLM, Hasselbaink DM, Koonen DYP, et al. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes 2004; 53: 1655-1663
33. Bonen A, Parolin ML, Steinberg GR, et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 2004; 18: 1144-1146
34. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy. J Mol Cell Cardiol 1997; 29:121-127
35. Bruce CR, Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 2004; 287(4):E616-21
36. Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 2004; 287:E182-187
37. Van Hall G, Steensberg A, Sacchetti M, et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 2003; 88: 3005-3010
38. Cooney GJ, Thompson AL, Furier SM, Ye J, Kraegen EW: Muscle long-chain acyl CoA esters and insulin resistance. Ann N Y Acad Sci 2002; 967:196-207
39. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglyceol, protein kinase C, and I?B-?.. Diabetes 2002; 51:2005-2011
40. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999; 274:24202-24210
41. Schmitz-Peiffer C, Browne CL, Oakes ND, et al. Alterations in the expression and cellular localization of protein kinase C isoforms ? and ? are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 1997; 46:169-178
42. Adams JM, II., Pratipanawatr T, Berria R, et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004; 53:25-31
43. Bruce CR, Thrush AB, Mertz VA, et al. Endurance training in obese humans improves glucose tolerance, mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 2006 in press
44. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328:238-244
45. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 2004; 62:333-9